vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $11.1M, roughly 1.9× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -373.3%, a 384.3% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
AUTL vs MDV — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $11.1M |
| Net Profit | $-79.1M | $1.2M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 45.8% |
| Net Margin | -373.3% | 11.0% |
| Revenue YoY | — | -5.6% |
| Net Profit YoY | 3.6% | -22.0% |
| EPS (diluted) | $-0.30 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $11.1M | ||
| Q3 25 | $21.2M | $11.7M | ||
| Q2 25 | $20.9M | $11.8M | ||
| Q1 25 | $9.0M | $11.8M | ||
| Q4 24 | — | $11.7M | ||
| Q3 24 | $0 | $11.7M | ||
| Q2 24 | $0 | $11.4M | ||
| Q1 24 | $10.1M | $12.0M |
| Q4 25 | — | $1.2M | ||
| Q3 25 | $-79.1M | $1.0M | ||
| Q2 25 | $-47.9M | $-2.0M | ||
| Q1 25 | $-70.2M | $829.0K | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | $-82.1M | $-587.0K | ||
| Q2 24 | $-58.3M | $1.3M | ||
| Q1 24 | $-52.7M | $3.7M |
| Q4 25 | — | 45.8% | ||
| Q3 25 | -337.9% | 41.4% | ||
| Q2 25 | -292.6% | 9.8% | ||
| Q1 25 | -726.3% | 40.2% | ||
| Q4 24 | — | 45.4% | ||
| Q3 24 | — | 42.0% | ||
| Q2 24 | — | 44.6% | ||
| Q1 24 | -384.1% | 55.6% |
| Q4 25 | — | 11.0% | ||
| Q3 25 | -373.3% | 9.0% | ||
| Q2 25 | -229.0% | -17.1% | ||
| Q1 25 | -781.1% | 7.0% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | -5.0% | ||
| Q2 24 | — | 11.6% | ||
| Q1 24 | -522.1% | 31.1% |
| Q4 25 | — | $0.02 | ||
| Q3 25 | $-0.30 | $0.00 | ||
| Q2 25 | $-0.18 | $-0.32 | ||
| Q1 25 | $-0.26 | $-0.01 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | $-0.31 | $-0.18 | ||
| Q2 24 | $-0.22 | $0.03 | ||
| Q1 24 | $-0.24 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $14.4M |
| Total DebtLower is stronger | — | $261.5M |
| Stockholders' EquityBook value | $265.5M | $162.7M |
| Total Assets | $661.9M | $476.5M |
| Debt / EquityLower = less leverage | — | 1.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $86.1M | $8.3M | ||
| Q2 25 | $123.8M | $5.8M | ||
| Q1 25 | $95.8M | $6.2M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | $657.1M | $6.8M | ||
| Q2 24 | $705.9M | $18.9M | ||
| Q1 24 | $758.5M | $18.4M |
| Q4 25 | — | $261.5M | ||
| Q3 25 | — | $279.7M | ||
| Q2 25 | — | $279.7M | ||
| Q1 25 | — | $279.7M | ||
| Q4 24 | — | $279.8M | ||
| Q3 24 | — | $279.7M | ||
| Q2 24 | — | $279.7M | ||
| Q1 24 | — | $279.6M |
| Q4 25 | — | $162.7M | ||
| Q3 25 | $265.5M | $164.8M | ||
| Q2 25 | $346.5M | $165.6M | ||
| Q1 25 | $371.1M | $171.1M | ||
| Q4 24 | — | $190.1M | ||
| Q3 24 | $477.0M | $186.3M | ||
| Q2 24 | $527.8M | $187.0M | ||
| Q1 24 | $582.0M | $188.0M |
| Q4 25 | — | $476.5M | ||
| Q3 25 | $661.9M | $499.6M | ||
| Q2 25 | $721.0M | $498.9M | ||
| Q1 25 | $746.3M | $506.8M | ||
| Q4 24 | — | $507.8M | ||
| Q3 24 | $827.5M | $507.4M | ||
| Q2 24 | $853.6M | $519.5M | ||
| Q1 24 | $901.4M | $522.5M |
| Q4 25 | — | 1.61× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | — | 1.50× | ||
| Q2 24 | — | 1.50× | ||
| Q1 24 | — | 1.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $15.0M |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | 12.34× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $15.0M | ||
| Q3 25 | $-67.9M | $4.1M | ||
| Q2 25 | $-72.8M | $3.9M | ||
| Q1 25 | $-75.6M | $3.0M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | $-76.7M | $5.1M | ||
| Q2 24 | $-51.1M | $4.7M | ||
| Q1 24 | $-40.5M | $3.0M |
| Q4 25 | — | — | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | — | ||
| Q1 25 | $-83.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | — | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | — | ||
| Q1 25 | -933.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 34.8% | — | ||
| Q1 25 | 91.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | — | 12.34× | ||
| Q3 25 | — | 3.95× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.68× | ||
| Q4 24 | — | 11.72× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.55× | ||
| Q1 24 | — | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
